Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease worsening compared with ...
Sep 28, 2025
0
31
A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University ...
Jul 31, 2025
0
30
Men are more susceptible than women to skin infections caused by Staphylococcus aureus bacteria, but the biological basis for this disparity has remained unclear. A new study led by UT Southwestern Medical Center researchers ...
Feb 27, 2026
0
30
A potential new male contraceptive drug has just undergone its first tests in human volunteers. The results give the first indication that the drug, which does not use artificial hormones or affect testosterone production ...
Jul 30, 2025
0
30
University of Kentucky Markey Cancer Center researchers have identified a cellular pathway that fuels the progression of aggressive, drug-resistant prostate cancer. The findings of the study, published in the Journal of Clinical ...
Aug 27, 2025
0
30
One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including frequent urination, difficulty starting urination, nocturia and a weak urine stream. Although these ...
Jul 7, 2026
0
30
A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored.
Jul 7, 2025
0
29
A new study from the American Cancer Society (ACS) reports that men diagnosed with non-metastatic prostate cancer who adopted the ACS Nutrition and Physical Activity Guideline for Cancer Survivors after diagnosis live longer. ...
Sep 27, 2025
0
29
Erectile disorder (ED) refers to a persistent difficulty achieving or maintaining an erection sufficient for satisfying sexual activity. It affects millions of men worldwide, including up to 1 in 4 in the United States. Beyond ...
Apr 26, 2026
0
29
Cornell scientists have taken a major step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, considered the holy grail of male contraception. A proof-of-principle study in ...
Apr 7, 2026
1
28
